News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Judith D. Bebchuk

Articles by Judith D. Bebchuk

TPS 105 ALISertib in Combination With Endocrine Therapy in Patients With Hormone Receptor-Positive, HER2-Negative Recurrent or Metastatic Breast Cancer: the Phase 2 ALISCA-Breast1 Study

ByPooja Advani, MBBS, MD,Sofia Braga,Adam M. Brufsky, MD, PhD,Karthik V. Giridhar,Erica L. Mayer, MD, MPH,Kelly E. McCann,Ruth M. O’Regan,Cristina Saura,Seth A. Wander,Georg F. Bischof,Beth H. Lowenthal,Judith D. Bebchuk,Lisa D. Eli,Brian G. Barnett,Joyce A. O’Shaughnessy,Tufia C. Haddad

April 11th 2025

Latest Updated Articles

Trending on CancerNetwork

Nogapendekin Alfa Combo Earns Approval in Saudi Arabia for Metastatic NSCLC

Gemogenovatucel-T Exhibits Survival Benefit in Epithelial Ovarian Cancer

Taiwan FDA Approves Nivolumab/Ipilimumab for MSI-H/dMMR Metastatic CRC

Radiotherapy Dose Escalation Did Not Improve Efficacy/QOL in Anal Cancer

FDA Grants Breakthrough Therapy Designation to ICT01 in Frontline AML